Quick Answer
GLOBUS MEDICAL INC reported Research And Development Expense of $147.25 million for the year ending 2025.
- GLOBUS MEDICAL INC showed a decrease of -10.1% in Research And Development Expense from 2024 to 2025.
- This data is from GLOBUS MEDICAL INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $5.92 million | Q1 2012: $6.74 million | Q2 2012: $6.94 million | Q3 2012: $7.02 million | Q1 2013: $6.85 million | Q2 2013: $7.04 million | Q3 2013: $6.57 million | Q1 2014: $7.44 million | Q2 2014: $7.69 million | Q3 2014: $8.15 million | Q1 2015: $8.66 million | Q2 2015: $9.08 million | Q3 2015: $9.25 million | Q1 2016: $10.03 million | Q2 2016: $10.59 million | Q3 2016: $10.27 million | Q1 2017: $10.67 million | Q2 2017: $10.71 million | Q3 2017: $10.89 million | Q1 2018: $12.69 million | Q2 2018: $13.52 million | Q3 2018: $15.53 million | Q1 2019: $14.32 million | Q2 2019: $15.75 million | Q3 2019: $14.51 million | Q1 2020: $15.40 million | Q2 2020: $39.46 million | Q3 2020: $14.42 million | Q1 2021: $14.92 million | Q2 2021: $15.55 million | Q3 2021: $15.85 million | Q1 2022: $17.41 million | Q2 2022: $17.40 million | Q3 2022: $18.70 million | Q1 2023: $21.08 million | Q2 2023: $21.35 million | Q3 2023: $29.33 million | Q1 2024: $57.27 million | Q2 2024: $37.70 million | Q3 2024: $35.38 million | Q1 2025: $33.06 million | Q2 2025: $39.95 million | Q3 2025: $38.07 million.
- Over the full 16 years of available data (2010 to 2025), GLOBUS MEDICAL INC's Research And Development Expense has grown by 591.0%.
- Historical annual values: Fiscal year 2025: $147.25 million | Fiscal year 2024: $163.75 million | Fiscal year 2023: $124.01 million | Fiscal year 2022: $73.02 million | Fiscal year 2021: $97.35 million | Fiscal year 2020: $84.52 million | Fiscal year 2019: $60.07 million | Fiscal year 2018: $55.50 million | Fiscal year 2017: $43.68 million | Fiscal year 2016: $44.53 million | Fiscal year 2015: $36.31 million | Fiscal year 2014: $31.17 million | Fiscal year 2013: $26.87 million | Fiscal year 2012: $27.93 million | Fiscal year 2011: $23.46 million | Fiscal year 2010: $21.31 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: